Enveric Biosciences's total assets for Q4 2025 were $5.10M, an increase of 16.82% from the previous quarter. ENVB total liabilities were $918.40K for the fiscal quarter, a 1.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.